341 related articles for article (PubMed ID: 9755855)
1. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3.
Amour A; Slocombe PM; Webster A; Butler M; Knight CG; Smith BJ; Stephens PE; Shelley C; Hutton M; Knäuper V; Docherty AJ; Murphy G
FEBS Lett; 1998 Sep; 435(1):39-44. PubMed ID: 9755855
[TBL] [Abstract][Full Text] [Related]
2. CD30 shedding from Karpas 299 lymphoma cells is mediated by TNF-alpha-converting enzyme.
Hansen HP; Dietrich S; Kisseleva T; Mokros T; Mentlein R; Lange HH; Murphy G; Lemke H
J Immunol; 2000 Dec; 165(12):6703-9. PubMed ID: 11120787
[TBL] [Abstract][Full Text] [Related]
3. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha.
Moss ML; Jin SL; Milla ME; Bickett DM; Burkhart W; Carter HL; Chen WJ; Clay WC; Didsbury JR; Hassler D; Hoffman CR; Kost TA; Lambert MH; Leesnitzer MA; McCauley P; McGeehan G; Mitchell J; Moyer M; Pahel G; Rocque W; Overton LK; Schoenen F; Seaton T; Su JL; Becherer JD
Nature; 1997 Feb; 385(6618):733-6. PubMed ID: 9034191
[TBL] [Abstract][Full Text] [Related]
4. Full-length and N-TIMP-3 display equal inhibitory activities toward TNF-alpha convertase.
Lee MH; Knäuper V; Becherer JD; Murphy G
Biochem Biophys Res Commun; 2001 Jan; 280(3):945-50. PubMed ID: 11162616
[TBL] [Abstract][Full Text] [Related]
5. The C-terminal domains of TACE weaken the inhibitory action of N-TIMP-3.
Lee MH; Verma V; Maskos K; Becherer JD; Knäuper V; Dodds P; Amour A; Murphy G
FEBS Lett; 2002 Jun; 520(1-3):102-6. PubMed ID: 12044879
[TBL] [Abstract][Full Text] [Related]
6. Tailoring tissue inhibitor of metalloproteinases-3 to overcome the weakening effects of the cysteine-rich domains of tumour necrosis factor-alpha converting enzyme.
Lee MH; Dodds P; Verma V; Maskos K; Knäuper V; Murphy G
Biochem J; 2003 Apr; 371(Pt 2):369-76. PubMed ID: 12556225
[TBL] [Abstract][Full Text] [Related]
7. TIMP-3 ameliorates hepatic ischemia/reperfusion injury through inhibition of tumor necrosis factor-alpha-converting enzyme activity in rats.
Tang ZY; Loss G; Carmody I; Cohen AJ
Transplantation; 2006 Dec; 82(11):1518-23. PubMed ID: 17164725
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the metalloproteinase domain of mouse TACE.
Amour A; Hutton M; Knäuper V; Slocombe PM; Webster A; Butler M; Knight CG; Smith BJ; Docherty AJ; Murphy G
Ann N Y Acad Sci; 1999 Jun; 878():728-31. PubMed ID: 10415820
[No Abstract] [Full Text] [Related]
9. Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
Wei S; Kashiwagi M; Kota S; Xie Z; Nagase H; Brew K
J Biol Chem; 2005 Sep; 280(38):32877-82. PubMed ID: 16079149
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases and TACE play a role in the pathogenesis of endometriosis.
Gottschalk C; Malberg K; Arndt M; Schmitt J; Roessner A; Schultze D; Kleinstein J; Ansorge S
Adv Exp Med Biol; 2000; 477():483-6. PubMed ID: 10849774
[TBL] [Abstract][Full Text] [Related]
11. Partial purification and characterization of a tumor necrosis factor-alpha converting activity.
Robache-Gallea S; Bruneau JM; Robbe H; Morand V; Capdevila C; Bhatnagar N; Chouaib S; Roman-Roman S
Eur J Immunol; 1997 May; 27(5):1275-82. PubMed ID: 9174621
[TBL] [Abstract][Full Text] [Related]
12. Tissue inhibitor of metalloproteinases-3 inhibits shedding of L-selectin from leukocytes.
Borland G; Murphy G; Ager A
J Biol Chem; 1999 Jan; 274(5):2810-5. PubMed ID: 9915814
[TBL] [Abstract][Full Text] [Related]
13. Total conversion of tissue inhibitor of metalloproteinase (TIMP) for specific metalloproteinase targeting: fine-tuning TIMP-4 for optimal inhibition of tumor necrosis factor-{alpha}-converting enzyme.
Lee MH; Rapti M; Murphy G
J Biol Chem; 2005 Apr; 280(16):15967-75. PubMed ID: 15713681
[TBL] [Abstract][Full Text] [Related]
14. Pronounced diversity in electronic and chemical properties between the catalytic zinc sites of tumor necrosis factor-alpha-converting enzyme and matrix metalloproteinases despite their high structural similarity.
Solomon A; Rosenblum G; Gonzales PE; Leonard JD; Mobashery S; Milla ME; Sagi I
J Biol Chem; 2004 Jul; 279(30):31646-54. PubMed ID: 15102849
[TBL] [Abstract][Full Text] [Related]
15. Cutting edge: a dominant negative form of TNF-alpha converting enzyme inhibits proTNF and TNFRII secretion.
Solomon KA; Pesti N; Wu G; Newton RC
J Immunol; 1999 Oct; 163(8):4105-8. PubMed ID: 10510344
[TBL] [Abstract][Full Text] [Related]
16. The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3.
Amour A; Knight CG; Webster A; Slocombe PM; Stephens PE; Knäuper V; Docherty AJ; Murphy G
FEBS Lett; 2000 May; 473(3):275-9. PubMed ID: 10818225
[TBL] [Abstract][Full Text] [Related]
17. The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs.
Amour A; Knight CG; English WR; Webster A; Slocombe PM; Knäuper V; Docherty AJ; Becherer JD; Blobel CP; Murphy G
FEBS Lett; 2002 Jul; 524(1-3):154-8. PubMed ID: 12135759
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis.
Zhang Y; Xu J; Levin J; Hegen M; Li G; Robertshaw H; Brennan F; Cummons T; Clarke D; Vansell N; Nickerson-Nutter C; Barone D; Mohler K; Black R; Skotnicki J; Gibbons J; Feldmann M; Frost P; Larsen G; Lin LL
J Pharmacol Exp Ther; 2004 Apr; 309(1):348-55. PubMed ID: 14718605
[TBL] [Abstract][Full Text] [Related]
19. Substrate specificity and novel selective inhibitors of TNF-alpha converting enzyme (TACE) from two-dimensional substrate mapping.
Lambert MH; Blackburn RK; Seaton TD; Kassel DB; Kinder DS; Leesnitzer MA; Bickett DM; Warner JR; Andersen MW; Badiang JG; Cowan DJ; Gaul MD; Petrov KG; Rabinowitz MH; Wiethe RW; Becherer JD; McDougald DL; Musso DL; Andrews RC; Moss ML
Comb Chem High Throughput Screen; 2005 Jun; 8(4):327-39. PubMed ID: 16101009
[TBL] [Abstract][Full Text] [Related]
20. Engineering N-terminal domain of tissue inhibitor of metalloproteinase (TIMP)-3 to be a better inhibitor against tumour necrosis factor-alpha-converting enzyme.
Lee MH; Verma V; Maskos K; Nath D; Knäuper V; Dodds P; Amour A; Murphy G
Biochem J; 2002 May; 364(Pt 1):227-34. PubMed ID: 11988096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
